Your browser doesn't support javascript.
loading
A Case of Recurrent Steroid-dependent Kikuchi-Fujimoto Disease Successfully Treated with Hydroxychloroquine / 임상소아혈액종양
Clinical Pediatric Hematology-Oncology ; : 144-147, 2017.
Article in English | WPRIM | ID: wpr-788606
ABSTRACT
Kikuchi-Fujimoto disease (KFD) is known as a self-limiting disease. The most common symptoms include fever, cervical lymphadenopathy, and pain, but nonspecific symptoms such as joint pain, nausea, chills, diaphoresis, and diarrhea may also be present. Its clinical course is generally benign, and symptoms including fever disappear within several months without special treatment. Thus, there is no specific recommended treatment for patients with KFD. However, some patients suffer from prolonged fever or systemic symptoms such as splenomegaly, skin rash, arthralgia, and aseptic meningitis. Many studies have reported the effectiveness of corticosteroids in patients with prolonged fever and systemic symptoms. Our patient also responded favorably to steroids; however, the disease relapsed while tapering. Recently, some studies reported the effectiveness of hydroxychloroquine (HC) in patients with KFD. Herein, we report successful treatment with HC in an adolescent patient with recurrent KFD dependent on steroids without any symptoms of autoimmune disease.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Autoimmune Diseases / Splenomegaly / Steroids / Adrenal Cortex Hormones / Arthralgia / Histiocytic Necrotizing Lymphadenitis / Chills / Diarrhea / Exanthema / Fever Limits: Adolescent / Child / Humans Language: English Journal: Clinical Pediatric Hematology-Oncology Year: 2017 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Autoimmune Diseases / Splenomegaly / Steroids / Adrenal Cortex Hormones / Arthralgia / Histiocytic Necrotizing Lymphadenitis / Chills / Diarrhea / Exanthema / Fever Limits: Adolescent / Child / Humans Language: English Journal: Clinical Pediatric Hematology-Oncology Year: 2017 Type: Article